Skip to content

ALDEYRA THERAPEUTICS, INC.: filings

Every ALDEYRA THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 50 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 202633930001341235-26-000010
10-Q2026-05-07fiscal Q1 202633680001341235-26-000006
10-K2026-02-27fiscal FY 202537740001193125-26-083012
10-Q2025-11-05fiscal Q3 202536980001193125-25-266989
10-Q2025-08-07fiscal Q2 202535960000950170-25-104971
10-Q2025-05-14fiscal Q1 202535720000950170-25-071602
10-K2025-02-28fiscal FY 202438750000950170-25-030102
10-Q2024-11-07fiscal Q3 202437990000950170-24-123248
10-Q2024-08-01fiscal Q2 202436970000950170-24-089238
10-Q2024-05-02fiscal Q1 202436730000950170-24-052056
10-K2024-03-07fiscal FY 202339770000950170-24-027933
10-Q2023-11-03fiscal Q3 2023381010000950170-23-058829
10-Q2023-08-03fiscal Q2 2023381010000950170-23-037934
10-Q2023-05-04fiscal Q1 202338770000950170-23-017827
10-K2023-03-09fiscal FY 202240800000950170-23-006998
10-Q2022-11-10fiscal Q3 2022381020000950170-22-024434
10-Q2022-08-05fiscal Q2 2022381020000950170-22-015115
10-Q2022-05-05fiscal Q1 202234700000950170-22-007890
10-K2022-03-17fiscal FY 202137730000950170-22-004111
10-Q2021-10-28fiscal Q3 202133840000950170-21-002456
10-Q2021-08-05fiscal Q2 202133840000950170-21-000925
10-Q2021-05-06fiscal Q1 202131630001564590-21-024943
10-K2021-03-11fiscal FY 202037720001564590-21-012501
10-Q2020-11-05fiscal Q3 202034850001564590-20-051290
10-Q2020-08-06fiscal Q2 202034860001564590-20-037714
10-Q2020-05-07fiscal Q1 202034680001564590-20-022912
10-K2020-03-12fiscal FY 201937710001564590-20-010493
10-Q2019-11-07fiscal Q3 201935880001564590-19-041846
10-Q2019-08-09fiscal Q2 201933850001564590-19-031031
10-Q2019-05-10fiscal Q1 201933670001564590-19-018542
10-K2019-03-08fiscal FY 201831620001564590-19-006997
10-Q2018-11-14fiscal Q3 201830750001193125-18-326837
10-Q2018-08-09fiscal Q2 201830750001193125-18-244346
10-Q2018-05-15fiscal Q1 201826550001193125-18-164070
10-K2018-03-29fiscal FY 201728560001193125-18-102077
10-Q2017-11-09fiscal Q3 201726690001193125-17-338853
10-Q2017-08-07fiscal Q2 201726680001193125-17-249864
10-Q2017-05-15fiscal Q1 201726520001193125-17-170649
10-K2017-03-30fiscal FY 201628550001193125-17-104228
10-Q2016-11-14fiscal Q3 201626670001193125-16-767770
10-Q2016-08-10fiscal Q2 201626670001193125-16-677524
10-Q2016-05-09fiscal Q1 201631620001193125-16-582737
10-K2016-03-30fiscal FY 201533650001193125-16-523952
10-Q2015-11-13fiscal Q3 201529810001193125-15-376648
10-Q2015-08-14fiscal Q2 201529790001193125-15-290681
10-Q2015-05-14fiscal Q1 201530580001193125-15-187962
10-K2015-03-23fiscal FY 201430550001193125-15-101703
10-Q2014-11-12fiscal Q3 201430790001193125-14-408602
10-Q2014-08-07fiscal Q2 201426740001193125-14-300661
10-Q2014-06-11fiscal Q1 201427800001193125-14-233411

Inspect the source

Entity
ALDEYRA THERAPEUTICS, INC. / CIK 0001341235
Captured
2026-09-20T07:54:15.451Z
SEC response SHA-256
71cda24b59474759e40949f545ab949ecdfc2871814e3cf45050931d1c516763

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001341235.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))